BGM Group Ltd (BGM) - Year-over-year net earnings per share growth for the last 12 months

Brandmark of BGM Group Corp (BGM)

BGM Group Ltd is scaling its operations through patents, ensuring high sales margins. Comparable quarterly EPS growth on the GURU.Markets system chart confirms this, with the current level sitting around 58.90. Revenues are based on the implementation of targeted therapy for rare pathologies, while process efficiency is enhanced through the robotization of packaging and the integration of AI-driven quality control.

bgm.ltd (BGM) Year-over-year net earnings per share trend for the last twelve months: for the period 08/13/2024 - 11/17/2026

BGM (BGM Group): analytical breakdowns and indicator data

- share price and expert price forecast:
Summary company analytics:BGM Group Ltd
Flagship merchandise of bgm.ltd

BGM Group Ltd (BGM) is investing significant resources into the development of targeted therapy and molecular modeling. The dynamics of these R&D expenditures directly impact the net profit distributed per share. This indicator measures the percentage change of this metric compared to the same quarter of the previous year. It allows for a real-time assessment of the actual efficiency in capitalizing scientific achievements. By analyzing the history of quarterly earnings per share changes, an investor can detect a slowdown in business growth rates in a timely manner.

Main competitors

VRTX: Quarterly EPS earnings growth|Earnings per share growth in annualized terms for the last twelve months Alnylam Inc. (ALNY)|INSM (Insmed) - Quarterly EPS earnings growth|Year-over-year earnings per share growth for the last 12 months UTHR (United Therapeutics Corporation)|Year-over-year net earnings per share growth for the last 12 months BMRN (BioMarin)|BBIO (BridgeBio Pharma) - Year-over-year earnings per one share growth for the last 12 months|Year-over-year earnings per share growth for the last twelve months Cogent Biosciences, Inc. COGT|XERS (Xeris Biopharma Inc) - Year-over-year net earnings per share trend for the last twelve months|Keros Therapeutics - Quarterly EPS earnings growth|Year-over-year earnings per one share growth for the last 12 months ARCT (Arcturus Therapeutics)|ETON: Quarterly EPS earnings growth|Kamada Ltd (KMDA) - Quarterly EPS earnings growth|Year-over-year earnings per share growth for the last twelve months Fulcrum Tx|ABEO: Year-over-year earnings per one share growth for the last 12 months|Year-over-year earnings per share growth for the last twelve months Mereo BioPharma Group (MREO)|Quarterly EPS earnings growth protalix.com (PLX)|Quarterly EPS earnings growth PLRX (Pliant Therapeutics Inc)|Quarterly EPS earnings growth Applied Therapeutics APLT|RNTX - Year-over-year earnings per share growth for the last twelve months|Net earnings per share growth for the trailing year gelteq.com (GELS)|AYTU (aytubio.com) - Year-over-year net earnings per share growth for the last 12 months|Chemomab Therapeutics Ltd - Year-over-year earnings per one share growth for the last 12 months|Year-over-year net earnings per share growth for the last 12 months SRXH|Year-over-year earnings per share growth for the last twelve months PLRZ|Quarterly EPS earnings growth AEZS|Year-over-year earnings per share growth for the last twelve months CYTH (Cyclo Therapeutics, Inc)|Inozyme Pharma - Year-over-year net earnings per share growth for the last 12 months|Reneo Pharmaceuticals, Inc. (RPHM) - Earnings per share growth in annualized terms for the last twelve months|COSCIENS Bio - Quarterly EPS earnings growth